Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

NAActive, not recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

June 14, 2024

Study Completion Date

August 31, 2024

Conditions
Heart Failure
Interventions
DEVICE

BiovitalsHF

BiovitalsHFTM is a cloud-based platform that incorporates continuous physiology data from remote vital signs monitoring devices and electronic patient reported outcome (ePRO) monitoring of subjects at-home to support GDMT dose titration for HFrEF patients.

Trial Locations (14)

20010

Medstar Washington Hospital Center, Washington D.C.

21218

Medstar Union Memorial Hospital, Baltimore

30306

Piedmont Athens Regional Medical Center, Athens

37920

University of Tennessee Medical Center, Knoxville

39216

Jackson Heart, Jackson

40207

Baptist Health Louisville Heart Failure Clinic, Louisville

45414

Premier Cardiovascular Institute, Dayton

48197

St Joseph Mercy, Ypsilanti

71301

Cambridge Medical Trials, Alexandria

72204

Cardiology and Medicine Clinic, Little Rock

78666

Austin Heart, San Marcos

89102

University of Medical Center of Southern Nevada, Las Vegas

97225

Providence St Vincent Medical Center, Portland

08901

Rutgers Robert Wood Johnson Medical School, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biofourmis Inc.

INDUSTRY